Delgado-Enciso Iván, Madrigal-Perez Violeta M, Lara-Esqueda Agustin, Diaz-Sanchez Martha G, Guzman-Esquivel Jose, Rosas-Vizcaino Luis E, Virgen-Jimenez Oscar O, Kleiman-Trujillo Juleny, Lagarda-Canales Maria R, Ceja-Espiritu Gabriel, Rangel-Salgado Viridiana, Lopez-Lemus Uriel A, Delgado-Enciso Josuel, Lara-Basulto Agustin D, Soriano Hernández Alejandro D
Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Department of Public Health, School of Medicine, University of Colima, Las Víboras, Colima 28040, Mexico.
Biomed Rep. 2018 Feb;8(2):156-159. doi: 10.3892/br.2018.1038. Epub 2018 Jan 2.
Potassium permanganate has been reported to be an effective treatment for certain types of wounds. The aim of the present study was to evaluate the use of potassium permanganate in the treatment of diabetic foot ulcers. A single-blind, randomized, controlled clinical trial was conducted on patients with type 2 diabetes mellitus that presented with a foot ulcer persisting for >3 months. The control group (n=10) was treated with the current standard treatment, which comprises of measures for reducing pressure in the ulcerated area, daily cleansing of the ulcer with potable water and antiseptic wash solution, and the application of a disinfectant solution on the entire surface area of the ulcer; while the intervention group (n=15) received the standard treatment plus 5% topical potassium permanganate solution applied once a day for 21 days. In the intervention group, 1 patient did not tolerate the treatment and was eliminated from the study on the first day. The remaining patients tolerated the interventions well. At the end of the treatment period, ulcers in the control group had decreased by 38% whereas those in the intervention group decreased by 73% (P<0.009). The degree of decrease was also investigated; the ulcer size was ≥50% decreased in 40% of patients in the control group and in 86% of patients in the intervention group (P=0.02). In conclusion, the results of the present study indicate that topical potassium permanganate is well tolerated and significantly accelerates the healing process of diabetic foot ulcers.
据报道,高锰酸钾是治疗某些类型伤口的有效药物。本研究的目的是评估高锰酸钾在治疗糖尿病足溃疡中的应用。对患有持续超过3个月足部溃疡的2型糖尿病患者进行了一项单盲、随机、对照临床试验。对照组(n = 10)采用当前标准治疗,包括减轻溃疡部位压力的措施、每天用饮用水和消毒清洗液清洗溃疡以及在溃疡的整个表面积上涂抹消毒溶液;而干预组(n = 15)接受标准治疗加5%局部高锰酸钾溶液,每天涂抹一次,持续21天。在干预组中,1名患者不耐受治疗,在第一天就退出了研究。其余患者对干预措施耐受良好。在治疗期结束时,对照组的溃疡面积减少了38%,而干预组减少了73%(P < 0.009)。还研究了减少程度;对照组40%的患者溃疡大小减少≥50%,干预组为86%(P = 0.02)。总之,本研究结果表明局部应用高锰酸钾耐受性良好,并能显著加速糖尿病足溃疡的愈合过程。